374 related articles for article (PubMed ID: 20156410)
1. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
Woods SW; Morgenstern H; Saksa JR; Walsh BC; Sullivan MC; Money R; Hawkins KA; Gueorguieva RV; Glazer WM
J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
[TBL] [Abstract][Full Text] [Related]
2. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
[TBL] [Abstract][Full Text] [Related]
3. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients.
Dolder CR; Jeste DV
Biol Psychiatry; 2003 Jun; 53(12):1142-5. PubMed ID: 12814866
[TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
Morgenstern H; Glazer WM
Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
7. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
8. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
van Harten PN; Hoek HW; Matroos GE; van Os J
J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
[TBL] [Abstract][Full Text] [Related]
9. Tardive dyskinesia and new antipsychotics.
Correll CU; Schenk EM
Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662
[TBL] [Abstract][Full Text] [Related]
10. Ten-year outcome of tardive dyskinesia.
Gardos G; Casey DE; Cole JO; Perenyi A; Kocsis E; Arato M; Samson JA; Conley C
Am J Psychiatry; 1994 Jun; 151(6):836-41. PubMed ID: 7910437
[TBL] [Abstract][Full Text] [Related]
11. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
12. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia rates with atypical antipsychotics in older adults.
Jeste DV
J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
[TBL] [Abstract][Full Text] [Related]
14. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
15. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
16. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
Szafrański T
Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
18. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
[TBL] [Abstract][Full Text] [Related]
19. Managing antipsychotic-induced tardive dyskinesia.
Gardos G
Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia in children treated with atypical antipsychotic medications.
Wonodi I; Reeves G; Carmichael D; Verovsky I; Avila MT; Elliott A; Hong LE; Adami HM; Thaker GK
Mov Disord; 2007 Sep; 22(12):1777-82. PubMed ID: 17580328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
